Our recent data also showed that IL4I1 expression is related to a microenvironment enriched in regulatory T cells and poor in granzyme B-positive CD8+ T cells in human primary cutaneous melanoma and is associated with a higher risk of poor outcome in patients [49]. The gene discussed is CD8A; the disease is cutaneous melanoma.